Literature DB >> 29885538

Immune checkpoint failures in inflammatory myopathies: An overview.

Sandrine Herbelet1, Jan L De Bleecker2.   

Abstract

Dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM), immune mediated necrotizing myopathy (IMNM) and overlap myositis (OM) are classified as inflammatory myopathies (IM) with involvement of autoimmune features such as autoreactive lymphocytes and autoantibodies. Autoimmunity can be defined as a loss in self-tolerance and attack of autoantigens by the immune system. Self-tolerance is achieved by a group of immune mechanisms occurring in central and periphal lymphoid organs and tissues, called immune checkpoints, that work in synergy to protect the body from harmful immune reactions. Autoimmune disorders appear when immune checkpoints fail. In this review, the different immune checkpoint failures are discussed in DM, PM, IBM and IMNM. Exploring research contribution in each of these immune checkpoints might help to highlight research perspectives in the field and obtain a more complete picture of IM disease pathology.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dermatomyositis; Immune mediated necrotizing myopathy; Immunity checkpoint failures; Inclusion body myositis; Polymyositis

Mesh:

Substances:

Year:  2018        PMID: 29885538     DOI: 10.1016/j.autrev.2018.01.026

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  1 in total

1.  Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?

Authors:  Mitchell S von Itzstein; Shaheen Khan; Vinita Popat; Rong Lu; Saad A Khan; Farjana J Fattah; Jason Y Park; Bonnie L Bermas; David R Karp; Murtaza Ahmed; Jessica M Saltarski; Yvonne Gloria-McCutchen; Yang Xie; Quan-Zhen Li; Edward K Wakeland; David E Gerber
Journal:  Oncologist       Date:  2020-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.